🌍·18h agoIndustry
Biomass Magazine: Why Use Living Cells? NLR Is Making Chemicals With Enzymes Alone
Publisher
e
eXoZymes
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- eXoZymes
- Region
- 最新
- Scope
- Industry
- Published
- June 30, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on exozymes.com
Leave the platform to read the original full article on the publisher site.
Source: eXoZymes
Scope: Industry
Related coverage
More related coverage
WuXi Biologics/7h ago
WuXi Biologics Receives Brazil ANVISA GMP Certification to Enable Global Commercial Manufacturing of Innovative Cancer Immunotherapy
Chugai Pharmaceutical News/7h ago
エンスプリングに関するロシュ社の発表について（甲状腺眼症に対する申請が米国FDAに受理）
Chugai Pharmaceutical/7h ago
Roche’s Announcement Regarding Enspryng (FDA Accepts Application for Thyroid Eye Disease)
Chugai Pharmaceutical News/8h ago